Literature DB >> 2862338

Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria.

H Lou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2862338     DOI： 10.1016/s0140-6736(85)90250-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

Review 1.  Phenylketonuria: a 21st century perspective.

Authors:  Francjan J van Spronsen
Journal:  Nat Rev Endocrinol       Date:  2010-09       Impact factor: 43.330

2.  The control of 5-hydroxytryptamine and dopamine synthesis in the brain: a theoretical approach.

Authors:  F A Hommes; J S Lee
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Phenylketonuria in adulthood: a collaborative study.

Authors:  R Koch; B Burton; G Hoganson; R Peterson; W Rhead; B Rouse; R Scott; J Wolff; A M Stern; F Guttler; M Nelson; F de la Cruz; J Coldwell; R Erbe; M T Geraghty; C Shear; J Thomas; C Azen
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

Review 4.  The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemia.

Authors:  F A Hommes
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine.

Authors:  C Lykkelund; J B Nielsen; H C Lou; V Rasmussen; A M Gerdes; E Christensen; F Güttler
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

6.  Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.

Authors:  J Pietz; R Kreis; A Rupp; E Mayatepek; D Rating; C Boesch; H J Bremer
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

7.  Phenylketonuria revisited: treatment of adults with behavioural manifestations.

Authors:  R L Brunner; E H Brown; H K Berry
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

8.  Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria.

Authors:  G M Knudsen; S Hasselbalch; P B Toft; E Christensen; O B Paulson; H Lou
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

9.  Large neutral amino acids in daily practice.

Authors:  Kirsten Kiær Ahring
Journal:  J Inherit Metab Dis       Date:  2010-03-19       Impact factor: 4.982

Review 10.  Large neutral amino acids in the treatment of PKU: from theory to practice.

Authors:  Francjan J van Spronsen; Martijn J de Groot; Marieke Hoeksma; Dirk-Jan Reijngoud; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2010-10-26       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.